Balanced news tone
News Sentiment
ASRT sentiment intelligence
Assertio Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+0.1% over one week, +0.3% over four weeks, trend active, and materially above fair value.
Press Release: Assertio Provides Update on Garda Therapeutics Tender Process
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Assertio's buyer raises its bid 21.1% to $21.80 a share
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Are Medical Stocks Lagging Assertio (ASRT) This Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Market source
How The Assertio Holdings (ASRT) Story Is Shifting With The Takeover And Reset Valuation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- Business Wire
Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Market source
Lake Street cuts Assertio stock rating on acquisition deal
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 09 Apr 2026 07:00
- Source
- Investing.com
H.C. Wainwright cuts Assertio stock rating on Garda acquisition
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 09 Apr 2026 07:00
- Source
- Investing.com
Assertio Holdings (ASRT) Issues 2026 Sales Guidance After Wider 2025 Losses Has The Bull Case Changed?
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 28 Mar 2026 07:00
- Source
- Market source
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should Know
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Zacks Investment Research
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Oncology push at Assertio: chasing up to $125M in 2026 sales
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- Stock Titan
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- Market source
How Assertio Holdings (ASRT) Narrative Is Shifting Around A Steady 37.44 Fair Value Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Mar 2026 08:00
- Source
- Market source
FDA appoints first-ever Chief AI Officer; the first at-home HPV test for cervical cancer screening is approved; Assertio to pay $3.6M for illegally marketing fentanyl spray beyond approved use – Morning Medical Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2025 07:00
- Source
- Medical Economics
Assertio Holdings (ASRT) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 18:27
- Source
- Stock Titan
Assertio Completed Merger with Zyla Life Sciences
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 May 2020 07:00
- Source
- PR Newswire
Assertio Therapeutics Agrees to Merge with Zyla Life
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2020 07:00
- Source
- GlobeNewswire